GUJTHEMBSEGujarat Themis Biosyn LtdMediumNeutral
Announced Fri, 29 May · 23:02 IST

Please refer to the attachment.

Strategic Transactions View source PDF

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹406.00
prior close
₹404.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.7-0.3+0.4-3.2-0.7+1.7+1.7-0.3-6.1-1.2-2.2
Up moveDown movePending
AI summary

Gujarat Themis Biosyn Limited has incorporated a new wholly owned subsidiary named 'Themis Biosyn Ireland Private Limited' in Ireland. The subsidiary was incorporated on 29th May 2026 with a share capital of 1,00,000 Euro. The new entity operates in the pharmaceutical industry and is 100% owned by the parent company. This filing is a disclosure under SEBI Listing Regulations and does not involve acquisition of an existing entity or related party transactions.

Likely market impact

The incorporation of this WOS signals the company's intent to expand its international presence in the pharmaceutical sector. While there is no immediate financial impact, this move could open new revenue avenues and markets for the company, which may be positive for long-term shareholders.